IDEXX Laboratories Stock Options
| IDXX Stock | USD 514.61 4.10 0.79% |
IDEXX Laboratories' latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 0.34 with a put-to-call open interest ratio of 0.93 over 57 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on October 17th 2025.
Open Interest Against October 17th 2025 Option Contracts
IDEXX Laboratories option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in IDEXX Laboratories' lending market. For example, when IDEXX Laboratories' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on IDEXX Laboratories, he or she must hedge the risk by shorting IDEXX Laboratories stock over its option's life.
2025-10-17
The chart above shows IDEXX Laboratories' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. IDEXX Laboratories' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for IDEXX Laboratories' option, there is no secondary market available for investors to trade.
IDEXX Laboratories Maximum Pain Price Across 2025-10-17 Option Contracts
Max pain occurs when IDEXX Laboratories' market makers reach a net positive position across all IDEXX Laboratories' options at a strike price where option holders stand to lose the most money. By contrast, IDEXX Laboratories' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on IDEXX Laboratories
Analyzing IDEXX Laboratories' in-the-money options over time can help investors to take a profitable long position in IDEXX Laboratories regardless of its overall volatility. This is especially true when IDEXX Laboratories' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money IDEXX Laboratories' options could be used as guardians of the underlying stock as they move almost dollar for dollar with IDEXX Laboratories' stock while costing only a fraction of its price.
IDEXX Laboratories In The Money Call Balance
When IDEXX Laboratories' strike price is surpassing the current stock price, the option contract against IDEXX Laboratories stock is said to be in the money. When it comes to buying IDEXX Laboratories' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on IDEXX Laboratories are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
IDEXX Current Options Market Mood
IDEXX Laboratories' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps IDEXX Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most IDEXX Laboratories' options investors are not very successful. IDEXX Laboratories' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current IDEXX contract
Base on the Rule 16, the options market is currently suggesting that IDEXX Laboratories will have an average daily up or down price movement of about 0.0213% per day over the life of the 2025-10-17 option contract. With IDEXX Laboratories trading at USD 514.61, that is roughly USD 0.11. If you think that the market is fully incorporating IDEXX Laboratories' daily price movement you should consider buying IDEXX Laboratories options at the current volatility level of 0.34%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing IDEXX Laboratories options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" IDEXX calls. Remember, the seller must deliver IDEXX Laboratories stock to the call owner when a call is exercised.
IDEXX Laboratories Option Chain
When IDEXX Laboratories' strike price is surpassing the current stock price, the option contract against IDEXX Laboratories stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
IDEXX Laboratories' option chain is a display of a range of information that helps investors for ways to trade options on IDEXX. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for IDEXX. It also shows strike prices and maturity days for a IDEXX Laboratories against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | IDXX251017C00680000 | 1 | 680.0 | 0.0 - 4.3 | 1.6 | Out |
Call | IDXX251017C00660000 | 5 | 660.0 | 0.0 - 2.9 | 1.65 | Out |
Call | IDXX251017C00640000 | 3 | 640.0 | 0.0 - 3.2 | 3.0 | Out |
Call | IDXX251017C00620000 | 7 | 620.0 | 0.0 - 4.1 | 8.0 | Out |
Call | IDXX251017C00600000 | 1 | 600.0 | 0.05 - 8.1 | 8.53 | Out |
Call | IDXX251017C00590000 | 9 | 590.0 | 0.05 - 9.0 | 9.0 | Out |
Call | IDXX251017C00580000 | 9 | 580.0 | 3.0 - 7.8 | 13.8 | Out |
Call | IDXX251017C00570000 | 6 | 570.0 | 4.1 - 10.9 | 13.6 | Out |
Call | IDXX251017C00560000 | 32 | 560.0 | 8.4 - 15.7 | 27.4 | Out |
Call | IDXX251017C00550000 | 7 | 550.0 | 11.3 - 16.6 | 28.4 | Out |
Call | IDXX251017C00540000 | 27 | 540.0 | 14.1 - 22.5 | 37.9 | Out |
Call | IDXX251017C00530000 | 43 | 530.0 | 18.6 - 26.2 | 46.36 | Out |
Call | IDXX251017C00520000 | 73 | 520.0 | 24.7 - 31.8 | 38.4 | Out |
Call | IDXX251017C00510000 | 2 | 510.0 | 31.0 - 37.6 | 31.0 | In |
Call | IDXX251017C00500000 | 11 | 500.0 | 36.1 - 43.5 | 42.12 | In |
Call | IDXX251017C00490000 | 3 | 490.0 | 42.9 - 49.9 | 42.9 | In |
Call | IDXX251017C00470000 | 6 | 470.0 | 56.6 - 64.5 | 56.6 | In |
Call | IDXX251017C00460000 | 1 | 460.0 | 64.5 - 72.1 | 84.0 | In |
Call | IDXX251017C00420000 | 1 | 420.0 | 98.0 - 105.9 | 98.0 | In |
Call | IDXX251017C00400000 | 1 | 400.0 | 116.3 - 125.0 | 116.3 | In |
Call | IDXX251017C00380000 | 15 | 380.0 | 135.3 - 143.9 | 135.3 | In |
Put | IDXX251017P00680000 | 0 | 680.0 | 160.8 - 169.6 | 160.8 | In |
Put | IDXX251017P00660000 | 0 | 660.0 | 140.9 - 150.0 | 140.9 | In |
Put | IDXX251017P00640000 | 0 | 640.0 | 120.8 - 129.6 | 120.8 | In |
Put | IDXX251017P00620000 | 0 | 620.0 | 100.9 - 110.0 | 100.9 | In |
Put | IDXX251017P00600000 | 0 | 600.0 | 81.2 - 90.6 | 81.2 | In |
Put | IDXX251017P00590000 | 0 | 590.0 | 73.8 - 80.4 | 73.8 | In |
Put | IDXX251017P00580000 | 0 | 580.0 | 64.0 - 71.9 | 64.0 | In |
Put | IDXX251017P00570000 | 3 | 570.0 | 56.0 - 64.9 | 43.9 | In |
Put | IDXX251017P00560000 | 12 | 560.0 | 49.0 - 55.8 | 42.3 | In |
Put | IDXX251017P00550000 | 0 | 550.0 | 41.1 - 50.6 | 41.1 | In |
Put | IDXX251017P00540000 | 1 | 540.0 | 35.0 - 43.8 | 46.8 | In |
Put | IDXX251017P00530000 | 8 | 530.0 | 29.0 - 38.2 | 23.5 | In |
Put | IDXX251017P00520000 | 10 | 520.0 | 24.0 - 32.9 | 24.33 | In |
Put | IDXX251017P00510000 | 4 | 510.0 | 19.7 - 28.4 | 31.1 | Out |
Put | IDXX251017P00500000 | 37 | 500.0 | 15.7 - 23.0 | 23.1 | Out |
Put | IDXX251017P00490000 | 57 | 490.0 | 12.2 - 20.9 | 10.5 | Out |
Put | IDXX251017P00480000 | 2 | 480.0 | 9.1 - 18.0 | 14.6 | Out |
Put | IDXX251017P00470000 | 3 | 470.0 | 6.5 - 13.7 | 16.7 | Out |
Put | IDXX251017P00460000 | 5 | 460.0 | 4.3 - 13.0 | 4.3 | Out |
Put | IDXX251017P00450000 | 6 | 450.0 | 2.2 - 11.1 | 11.21 | Out |
Put | IDXX251017P00440000 | 1 | 440.0 | 0.9 - 9.4 | 0.9 | Out |
Put | IDXX251017P00430000 | 5 | 430.0 | 0.05 - 6.8 | 2.9 | Out |
Put | IDXX251017P00420000 | 11 | 420.0 | 0.05 - 5.5 | 2.35 | Out |
Put | IDXX251017P00410000 | 4 | 410.0 | 0.0 - 4.8 | 1.9 | Out |
Put | IDXX251017P00400000 | 1 | 400.0 | 0.0 - 3.7 | 2.7 | Out |
Put | IDXX251017P00390000 | 1 | 390.0 | 0.0 - 4.8 | 4.8 | Out |
Put | IDXX251017P00380000 | 10 | 380.0 | 0.0 - 3.3 | 3.3 | Out |
Put | IDXX251017P00360000 | 1 | 360.0 | 0.0 - 3.0 | 3.0 | Out |
Put | IDXX251017P00350000 | 12 | 350.0 | 0.0 - 2.9 | 2.9 | Out |
Put | IDXX251017P00340000 | 1 | 340.0 | 0.0 - 4.4 | 4.4 | Out |
Put | IDXX251017P00330000 | 4 | 330.0 | 0.0 - 4.3 | 2.26 | Out |
Put | IDXX251017P00320000 | 3 | 320.0 | 0.0 - 1.6 | 1.6 | Out |
Put | IDXX251017P00310000 | 10 | 310.0 | 0.0 - 1.4 | 1.4 | Out |
Put | IDXX251017P00260000 | 1 | 260.0 | 0.0 - 4.3 | 4.3 | Out |
Put | IDXX251017P00250000 | 30 | 250.0 | 0.0 - 4.8 | 0.8 | Out |
Put | IDXX251017P00220000 | 1 | 220.0 | 0.0 - 4.3 | 4.3 | Out |
IDEXX Laboratories Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
IDEXX Total Stockholder Equity
Total Stockholder Equity |
|
IDEXX Laboratories Corporate Management
| Jeffrey Carr | GM VP | Profile | |
| Sharon JD | General VP | Profile | |
| Nimrata PE | Executive Commercial | Profile | |
| Julie Godon | Senior Officer | Profile | |
| Emilia Bostater | Officer Architecture | Profile |
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.